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ABSTRACT 
Purpose. The benefits of aerobic exercise training on insulin sensitivity in subjects with the 
metabolic syndrome (MetS) are, at least in part, associated with changes in cytokines. Recent 
studies identified novel cytokines (e.g. fractalkine, omentin and osteopontin) that are strongly 
involved in glucose homeostasis and therefore potentially contribute in the exercise-induced 
changes in insulin sensitivity. Therefore, we aim to examine changes in skeletal muscle RNA 
expression and plasma levels of novel cytokines after exercise training, and correlate these 
changes to the exercise-induced changes in insulin sensitivity. Methods. Women with the 
metabolic syndrome (MetS, n=11) and healthy women (n=10) participated in a 6-month aerobic 
exercise training intervention (3/week, 45min per session at 65%-85% of individual heart rate 
reserve). Before and after training, we examined insulin sensitivity (M-value during 
hyperinsulinemic euglycaemic clamp), circulating blood levels of cytokines (venous blood 
sample; leptin, adiponectin, omentin, fraktalkin, osteopontin). Skeletal muscle RNA-expression 
of these cytokines (muscle biopsy) was examined in two subgroups (MetS n=6; healthy women 
n=6). Results. At baseline, plasma levels of omentin (85.8±26.2ng/ml) and adiponectin 
(5.0±1.7μg/ml) levels were significantly higher in controls compared to MetS (51.1±27.1; 
3.6±1.1 respectively), and leptin levels were lower in controls (18.7±11.5ng/ml vs 53.0±23.5). 
M-value was significantly higher in controls (8.1±1.9mg/kg/min) than in MetS (4.0±1.7). 
Exercise training significantly improved M-values in both groups (P<0.01). Exercise training did 
not alter plasma and skeletal muscle RNA-expression levels of cytokines, whilst no correlation 
was observed between changes in cytokine level/RNA-expression and M-values (P>0.05). 
Conclusion. Whilst exercise training successfully improves insulin sensitivity in MetS and 
healthy women, we found no change in plasma and mRNA expression levels of novel cytokines. 
Keywords: metabolic syndrome, exercise training, RNA-expression 
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INTRODUCTION 
The metabolic syndrome (MetS) comprises a set of interrelated risk factors resulting in an 
increased risk for development of type 2 diabetes mellitus and cardiovascular diseases.(13, 26) 
The pathophysiology of MetS is characterized by the presence of peripheral insulin resistance, 
which is caused by a low physical activity level and excessive central adiposity.(11) Several 
previous intervention studies have demonstrated that exercise training is a powerful, non-
pharmacological tool to improve insulin sensitivity via a number of metabolic adaptations.(18, 
32) Part of these adaptations may be related to exercise-induced alterations in cytokines. These 
pro- and anti-inflammatory factors play a pivotal role in the presence of low-grade inflammation 
that underlies a decline in insulin sensitivity.(19, 37) Therefore, the measurement of cytokines 
prior to and after exercise training may provide potential insight in the mechanisms underlying 
the benefits of exercise training on insulin sensitivity. 
 
Recent studies have identified novel cytokines, which may play an important role in glucose 
homeostasis and the presence of inflammation. Fractalkine is secreted in both adipose tissue and 
skeletal muscle,(5, 36) and plays a role in the regulation of pancreatic islet β cell function. In 
humans, fractalkine has been proven to modulate monocyte adhesion in adipose tissue, thereby 
influencing chronic inflammation processes,(36) and is independently associated with markers of 
insulin resistance (HOMA-IR).(10) Omentin is a cytokine mainly secreted by visceral adipose 
tissue. Circulating omentin levels are negatively correlated with insulin resistance and are 
decreased in obesity and type 2 diabetes.(39) Osteopontin is biosynthesized in numerous cell 
types including macrophages and myoblasts in skeletal muscle.(41) In rodents, osteopontin 
influences macrophage recruitment in adipose tissue and thereby contributes to the inflammatory 
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state. In obesity models in mice, circulating osteopontin levels are increased, whilst mice with a 
lack in osteopontin display improved insulin sensitivity.(28) Finally, vaspin is a cytokine that is 
mainly secreted in visceral adipose tissue and is reported to have insulin-sensitizing effects in 
rodents. (2, 45) Currently, it is not known whether the benefits of exercise training on insulin 
sensitivity are related to changes in these novel cytokines. 
 
The first aim of this study was to examine whether 6 months of aerobic exercise training alters 
circulating levels as well as RNA-expression levels in skeletal muscle of a set of selected novel 
(i.e. fractalkine, omentin, osteopontin, vaspin) and traditional (i.e. adiponectin, leptin and 
interleukin-6) cytokines, and whether these changes are associated with exercise training-
induced adaptations in insulin sensitivity in subjects with MetS and healthy controls. We 
hypothesize that the benefits of aerobic exercise training on insulin sensitivity in MetS may be 
associated with alterations in levels of these cytokines. 
 
METHODS 
Subjects 
Eleven women with MetS and ten lean, age-matched, sedentary control women were included in 
this study. Metabolic syndrome was defined as having at least three out of five criteria as defined 
in the Joint Scientific Statement for Harmonizing the Metabolic Syndrome, including waist 
circumference >88 cm, triglycerides >1.7 mmol/l, High Density Lipoprotein (HDL)-cholesterol 
<1.3 mmol/l, blood pressure >130/85 mmHg and/or the use of antihypertensive medication, and 
fasting glucose levels >6.1 mmol/l.(1) Lean women were defined as having a body mass index 
(BMI) <25 kg/m² and the absence of all metabolic syndrome criteria. Pre-, peri- and 
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postmenopausal women were included. Women were considered peri-menopausal when they 
experienced a persistent change in menstrual cycles of at least seven days, or a period of 
amenorrhea of 60 days or more. Post-menopause was defined as a period of amenorrhea of 12 
months or more.(15) We excluded women with a medical history of known diabetes mellitus 
and/or cardiovascular diseases, liver or renal diseases, smoking, who consume more than two 
units of alcohol (10 g) a day, or perform regular physical activity >2 hours a week. Before 
participation, written informed consent was obtained. This study was approved by the Medical 
Ethical Committee of the Radboud university medical center, and was conducted in accordance 
with the Declaration of Helsinki (2000). 
 
Study design 
All subjects who participated in this study were engaged in a six month aerobic exercise training 
intervention. Before and after the intervention, a venapunction, hyperinsulinemic, euglycemic 
clamp, vastus lateralis muscle biopsy and a maximal cycling test was conducted in each 
participant.  
 
Exercise training 
During this training study, all women trained three times a week under the supervision of an 
experienced researcher. Training consisted of cycling exercise on an ergometer (Lode, 
Groningen, the Netherlands) starting with a 10 minute warming-up, followed by 30 minutes of 
exercise at 65% of the individual heart rate reserve (HRR) and ending with a cooling-down of 5 
minutes. Workload was increased based on improvements in physical fitness level across the six 
month intervention. Exercise intensity was monitored and documented with the use of heart rate 
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monitors (Polar). Women had to attend at least 90% of the training session during this six month 
period to be eligible for inclusion of the statistical analysis.  
 
Measurements 
Insulin sensitivity. Peripheral tissue sensitivity to exogenous insulin was measured using a 
hyperinsulinemic euglycemic clamp as previously described.(8) The clamp was performed at 
least 48 hours after cessation of the last exercise bout. After an overnight fast (10 hours), the 
subject was placed in the supine position in a quiet, temperature controlled (22 – 24 ºC) room. 
Insulin (Actrapid, Novo-Nordisk, Copenhagen, Denmark) was infused intravenously in a dose of 
430 pmol·m
-2
·min
-1
 (60 mU · m
-2 
· min
-1
) for 120 minutes. Insulin 50 U · ml
-1
 was diluted in 48 
ml NaCl 0.9% with the addition of 2 ml blood from the subject to a concentration of 1 U·ml
-1
. 
Venous plasma glucose concentrations were clamped at 5.0 mmol·L
-1
 by a variable glucose 20% 
infusion rate, adjusted depending on venous plasma glucose level measured at 5-minute 
intervals. Venous plasma glucose was measured in duplicate, in samples that were immediately 
centrifuged during 10 seconds, with use of the glucose oxidation method (Beckman Glucose 
Analyzer 2, Beckman Instruments Inc, Fullerton, CA 92634, USA). Insulin was measured in 
duplicate conform international standard 83/500 by an in-house radio-immunoassay (RIA) with 
the use of an anti-human insulin antiserum raised in guinea pig and radio-iodinated insulin as a 
tracer. Bound/free separation was carried out by addition of sheep anti-guinea-pig antiserum and 
precipitation by means of polyethylene glycol (PEG). Between and within-run coefficients of 
variation were 4.6% and 5.8% respectively, at a level of 33mU·L
-1
. Whole body glucose disposal 
during the last 30 minutes of the euglycemic clamp was calculated as the M-value. 
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Plasma cytokine levels. Fasting venous blood samples collected prior to the start of the 
hyperinsulinemic euglycemic clamp were used to determine glucose, cholesterol and 
triglycerides via standard laboratory methods. Fasting venous blood was sampled at least 48 
hours after cessation of the last exercise bout. Adiponectin and leptin were measured in duplicate 
by using DuoSet ELISA development system kits (R&D systems, Minneapolis, USA), free fatty 
acids (FFA) using Cobas Mira Plus (Roche Diagnostics Ltd., Basal, Switzerland), inflammatory 
marker C-reactive protein by Dako high-sensitivity ELISA (Glostrup, Denmark) and fractalkine, 
omentin. osteopontin, vaspin and interleukin 6 (IL-6) by Luminex assay (Austin, Texas, USA). 
 
Skeletal muscle cytokine RNA gene expression. Before and after the six month training period, 
biopsies from the vastus lateralis muscle were taken after a standardized 250 kcal breakfast (79% 
carbohydrates, 11.2% protein, 9.8% fat). The muscle biopsies after the exercise training period, 
were taken at least 48 hours after the last exercise session. From muscle biopsies of six women 
of each group total RNA was isolated and purified. The physiological characteristics of these 
subgroups were representative for the whole group (see Table, Supplemental Digital Content 1, 
Characteristics of the entire group versus the subgroups, http://links.lww.com/MSS/A722). RNA 
concentration and purity were measured with a Nanodrop spectrophotometer (Thermo Scientific, 
Waltham, MA,USA). RNA integrity was analyzed on an Agilent Bioanalyser (Santa Clara, CA, 
USA). RNA gene expression profiling was performed using Affymetrix GeneChip Human Gene 
1.0 ST arrays (Affymetrix Inc., Santa Clara, CA, USA), according to the manufacturer’s 
instruction. The average fluorescence intensity of all genes was calculated using the Robust 
Multiarray Analysis (RMA) Algorithm, including a quantile normalization and using a 
background correction for GC-content.(20) Microarray analysis was performed using 
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MADMAX pipeline for statistical analysis of microarray data.(24) Quality control was 
performed and all arrays met our criteria, except arrays from three participants. Data of these 
participants was excluded from further analysis. Microarray data were filtered, and probe sets 
with expression values higher than 20 on more than 5 arrays were considered to be expressed and 
were selected for further statistical analysis. Significant differences in expression levels were 
assessed using Intensity-Based Moderated T-statistics (IBMT).(35) Gene expression was defined 
as significantly changed when the p-value was <0.01, an alpha that is commonly used in gene 
expression studies.(5, 35) The protocol used was compliant with the MIAMI guidelines, and data 
have been submitted to the Gene Expression Omnibus (GEO) repository under no. GSE43760. 
 
Antropometry. Before and after six months of endurance training we examined height and body 
weight (Seca 888 Scale, Seca, Hamburg) to calculate body mass index (BMI). Waist and 
abdominal circumference were measured with a measuring tape (Seca 201, Chino, USA) to 
calculate waist-to-hip ratio. Plasma cholesterol, triglyceride and glucose were determined in 
fasting venous blood samples using standard laboratory methods. Before and after the training 
period a total body Dual-X-ray Absorptiometry (DXA) scan was performed to determine lean 
body mass, total fat mass and trunk fat mass (QDR 4500 densitometer, Hologic Inc. Waltham, 
MA). 
 
Daily activity levels. At baseline, daily activity levels were assessed with an accelerometer 
(SenseWear Pro3 Armband, Body Media Inc., Pitssburgh, PA, USA). From each 24 hour 
interval, data were analyzed from 0700 to 2300 h with a minimum on-body time of 85%. At least 
three days had to fulfill these criteria to be used for analysis. Time per day spent in vigorous 
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intensity activities (>6.0 METs) and time per day in very vigorous intensity activity (>9.0 METs) 
were calculated.(16) 
 
Dietary intake. During the training intervention, women were instructed not to change their 
caloric intake. To assess potential changes in daily food intake, women were asked to record 3-
day dietary intake records before and in the last week of the training intervention. Dietary 
records were analyzed with Eetmeter Software (Voedingscentrum, the Hague, Netherlands). 
Only data of women who completed the dietary records on at least three days before and at the 
end of the training period was included for analysis. 
 
Cardio-respiratory fitness level. Women performed a maximal exercise test on an electrically 
braked leg-cycling ergometer (Lode, Angio 300, Groningen, the Netherlands) using an 
incremental protocol, to assess their cardio-respiratory fitness level. Workload increased by 10 
W per minute, starting at 10 W, until exhaustion. A gas-analyzer was used to measure oxygen 
consumption continuously (Jaeger Benelux BV, Breda, the Netherlands). Maximal oxygen 
consumption (VO2max) was analyzed as the mean of the last minute of the exercise bout. During 
the test, heart rate was measured continuously. Two minutes after cessation of the test, capillary 
blood lactate level (Roche Diagnostics GmbH, Mannheim, Germany) was measured. 
 
Statistical analysis 
All statistical analyses were conducted in SPSS 20 (Statistical Package for Social Sciences 20.0, 
SPSS Inc., Chicago, Illinois, USA). The sample size calculation to achieve statistical power were 
based on data from previous research published on the effects of exercise training on circulating 
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leptin levels in obese individuals.(23) The estimated sample size was 10 participants in order to 
detect a difference of 4.1 ng/ml in leptin levels after training (α=0.05, β=0.85). Baseline 
characteristics of the groups were compared with the use of an unpaired t-test. A Two-way 
repeated ANOVA was used to examine the impact of exercise training on VO2max, insulin 
sensitivity and cytokines. Correlations between circulating levels of cytokines and the M-value 
were assessed with the use of Spearman’s correlation coefficient. The level of statistical 
significance for data except the microarray data was defined at α=0.05. In the microarray 
analysis, genes were defined as significantly changed at α=0.01. Data are presented as mean ± 
SD, unless stated otherwise. 
 
RESULTS 
Subject characteristics 
The physical characteristics of the women with the MetS and the lean sedentary controls are 
presented in Table 1. In both groups pre-, peri- and post-menopausal women were included 
(Table 1). None of the included women used hormone replacement therapy, since this is known 
to directly influence circulating cytokine levels(38). As a consequence of the selection 
procedure, women with MetS demonstrated a significantly higher body weight, BMI, blood 
pressure and triglycerides at baseline (Table 1). Analysis of physical activity data at baseline 
demonstrated that the women with MetS spent 10 minutes per day in vigorous intensity activities 
and 0 minutes per day in very vigorous intensity activities. Lean controls spent on average 19 
minutes per day in vigorous intensity activities and 0 minutes per day in very vigorous intensity.  
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Exercise training intervention 
Eleven women with MetS and ten lean control women all successfully completed the exercise 
intervention, with a training compliance of 92%. Cardio-respiratory fitness, determined as the 
peak oxygen uptake, improved significantly in both MetS and the lean control women, but 
improvement did not differ between the two groups (Table 1). Waist circumference improved 
significantly in both groups, whereas other body composition measurements showed no change 
over time, but remained different between the two groups. Analysis of the dietary records in a 
subgroup of women (MetS n = 4; lean control women n =5) showed no significant change in 
caloric intake during the training intervention (pre: 7.6 ± 1.2 MJ/day; post: 7.2 ± 1.2 MJ/day; p = 
0.12). Circulating markers of glucose homeostasis (i.e. fasting glucose and insulin) and lipids 
showed no change over time in both groups, whilst blood pressure decreased (Table 1). Insulin 
sensitivity (M-value) improved significantly in both groups, with no differences in the magnitude 
of improvement between both groups (Figure 1). Three out of eleven women with the metabolic 
syndrome (27%) did not meet the criteria for the metabolic syndrome anymore after six months 
of cycling training.  
 
Cytokines 
Plasma cytokine levels. At baseline, plasma levels of omentin and adiponectin were significantly 
higher in healthy control women, whilst leptin levels were lower in healthy women compared to 
women with MetS. No differences between the groups were found for the other cytokines 
(Figure 2). Exercise training did not change plasma levels of cytokines in both groups (Figure 2). 
At baseline, circulating vaspin did not reach the minimum detecting value of 0.16 ng/ml in n=8 
women with the metabolic syndrome and in n=6 lean control women. Plasma levels of IL-6 did 
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not meet the minimal detection value of 3 pg/ml at baseline in all lean control women (n=10) and 
in most women with the metabolic syndrome (n=9). After the training period, levels of both 
vaspin and IL-6 remained below our minimal detection limit in these subjects. Since a large 
proportion of the individuals included in this study did not show detectable circulating IL-6 and 
vaspin levels, data on both IL-6 and vaspin were excluded from further analysis.  
 
Skeletal muscle mRNA expression. Skeletal muscle gene expression levels of novel and known 
cytokines were compared before and after the training intervention in five women with the 
metabolic syndrome and four lean control women. In both groups, no differences were found in 
gene expression levels of the cytokines before and after exercise training (Table 2).  
 
Correlation analysis 
At baseline we found a significant inverse correlation between insulin sensitivity (i.e. M-value) 
and circulating levels of leptin (R=0.65, P=0.002), whereas no correlation was found between the 
M-value and adiponectin (R=0.35, P=0.124), fractalkine (R=-0.22, P=0.33), omentin (R=0.38, 
P=0.09), or osteopontin (R=0.14, P=0.55). When exploring the exercise training induced changes 
in insulin sensitivity (ΔM-value) and the changes in cytokines (ΔFractalkine (R=-0.36, P=0.18); 
ΔOmentin (R=0.22, P=0.34) ; ΔOsteopontin (R=-0.13, P=0.59), ΔLeptin (R=-0.24, P=0.29), 
ΔAdiponectin(R=0.37, P-0.10)), no significant correlations were found. Furthermore, no 
correlation between weight change (Δweight) and changes in ΔFractalkine (R=-0.20, P=0.40) ; 
ΔOmentin (R=-0.25, P=0.27); ΔOsteopontin (R=0.10, P=0.68), ΔLeptin (R=-0.22, P=0.34) or 
ΔAdiponectin (R=0.06, P =0.79) was present. 
 
AC
CE
PT
ED
Copyright © 2016 by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited.
DISCUSSION  
Our results confirm that exercise training successfully improves insulin sensitivity, in both 
women with the metabolic syndrome and lean, sedentary controls. The improvement in insulin 
sensitivity after exercise training was not accompanied by changes in circulating levels of novel 
(i.e. fractalkine, omentin, osteopontin and vaspin) and traditional (i.e. leptin, adiponectin and IL-
6) cytokines. Furthermore, gene expression levels of these cytokines in skeletal muscle did not 
change after exercise training. Taken together, these results suggest that cytokines are not 
associated with exercise-induced improvements in insulin sensitivity in women. 
 
Baseline 
In this study, we confirmed with use of the M-value as a gold standard technique, that insulin 
sensitivity in women with the MetS is significantly lower compared to age-matched lean 
controls. Furthermore, we found that lean controls show lower leptin levels, and higher omentin 
and adiponectin levels than women with MetS. Whilst previous research showed that omentin is 
lower in subjects with obesity and type 2 diabetes, this study is the first to show that omentin is 
also lower in women with MetS compared to controls.(34, 39) Previous studies found that 
fractalkine, osteopontin and vaspin are associated with insulin resistance and obesity.(2, 10, 36) 
However, no baseline differences in circulating levels of cytokines were found between women 
with MetS and controls in our study. Furthermore, we found no correlation between insulin 
sensitivity and levels of these cytokines. One important difference with previous studies is that 
we used the gold standard to measure insulin sensitivity rather than the less invasive, but also 
less reliable oral glucose tolerance test (OGTT). Such measures for insulin sensitivity, that use 
fasting levels of glucose and insulin have clear limitations,(30) and should therefore be 
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interpreted with caution to examine the relationship between cytokines and insulin sensitivity. 
With the use of M-value, our study tempers the results of previous work that suggested an 
association between serum levels of fractalkine, omentin, osteopontin, vaspin with insulin 
sensitivity. 
 
Training 
Six months of aerobic exercise training significantly improved VO2max in both women with MetS 
and sedentary control women. In both groups, no changes in body mass and waist to hip ratio 
were observed. Furthermore, circulating levels of cytokines and their gene expression in skeletal 
muscle did not change after training. The effect of aerobic exercise training on leptin and 
adiponectin is not clear and conflicting results have been reported.(4, 40) Some studies showed a 
decrease in leptin levels after aerobic exercise training in obese women,(14, 23, 31) whilst others 
demonstrated no change.(31) Some studies have shown that adiponectin increases after exercise 
training in obese subjects,(3, 6) but also an absence of a response has been reported.(17, 31) In 
our study we found no change in leptin and adiponectin both in circulating serum levels and on 
gene expression level in skeletal muscle, despite the significant improvement in M-value. 
Furthermore, our correlation analysis was unable to demonstrate an association between changes 
in leptin and adiponectin and changes in M-value. Taken together, it is unlikely that leptin or 
adiponectin play a pivotal role in the mechanisms underlying a change in M-value by exercise 
training.  
 
The response of omentin, fractalkine and osteopontin to exercise training in humans have 
scarcely been studied and evidence is inconclusive. Omentin has been studied most extensively 
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in relation to exercise training of non-diabetic individuals and in combination with parameters of 
glucose homeostasis. Saremi et al. reported an increase in circulating omentin levels after 12 
weeks of aerobic exercise (5x/week, 50-60 minutes), which was accompanied by a significant 
decrease in HOMA-IR and significant weight loss.(34) Another study reported no effect of 3 
months (3x/week, 30 minutes) of exercise on circulating omentin levels women, whilst BMI and 
HOMA-IR decreased significantly.(34, 43) One previous study by Catoire et al. examined the 
response of fractalkine to combined exercise training (2x/ week endurance exercise; 1x/week 
resistance exercise; 45 minutes each) of 12 weeks and found no change in RNA expression 
levels and circulating levels of fractalkine.(5) Our study confirms these findings after a 6 month 
endurance training intervention in women. Two previous studies investigated circulating 
osteopontin levels before and after an aerobic training intervention, without assessing 
measurements of insulin sensitivity and both found no change. (9) (44) In line with previous 
work our study demonstrates that omentin, osteopontin and fractalkine do not change after 
training. An important difference between studies that did find an effect on cytokines versus 
those who did not is the presence of weight loss. It has been suggested in previous reviews that 
considerable weight loss (of at least 5%) is needed to achieve a change in cytokine 
expression,(22, 40) and thereby circulating levels. However, in exercise training studies the 
relation between weight loss and change in cytokines seems less clear. In some exercise studies 
significant weight loss is present, whilst no change in cytokines occurred.(9, 34, 43) 
Furthermore, endurance training does not necessarily result in weight loss. During endurance 
training adipose tissue depots may decrease, whilst lean body mass and/or circulating blood 
volume may increase.(7, 21, 33) These counteracting processes may result in the absence of 
weight loss during exercise training. Indeed, in our study no correlation was present between 
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weight change and change in circulating cytokines. Furthermore, we demonstrated significant 
and clinically relevant improvements in VO2max and insulin sensitivity in the absence of weight 
loss and changes in plasma cytokine levels and skeletal muscle RNA expression. This suggests 
that exercise-induced improvements in glycemic control are not accompanied by a change in 
cytokines.  
 
Another explanation for the differences between training studies on cytokine responses might be 
related to training frequency and intensity(42) Whilst we implemented a training frequency of 
three times per week, Saremi implemented a frequency of five training sessions per week and 
found a significant increase in omentin levels.(34) Urbanova et al. implemented a 3x/week 
protocol and found no change in omentin levels.(43) Several studies that investigated leptin and 
adiponectin applied similar training frequency and found conflicting cytokine responses.(3, 6, 
14, 23) Possibly, a higher training frequency may be needed to cause a change cytokines. 
 
A more plausible explanation for the absence of changes in circulating cytokines and their 
expression in skeletal muscle in our study relates to a difference in time-dependent responses of 
cytokines and M-value to exercise training. Each training bout elicits acute changes in energy 
metabolism and homeostasis, and also in circulating cytokine levels and their expression. Some 
acute changes in cytokines and their expression will persist for hours, whilst others quickly 
disappear after cessation of exercise.(12, 25) Potentially, the cytokine response to an acute bout 
of exercise can influence metabolic adaptations that contribute to a change in insulin sensitivity. 
However, with our study design acute changes in cytokines after exercise were not examined. In 
the discussed exercise training studies, blood (and tissue) samples were collected at 24 hours,(9, 
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14) 48 hours(34, 44) or 72 hours(31) after the last exercise session, whilst the majority of the 
authors did not report the timing of sampling. Considering the responses of cytokines to an acute 
exercise bout, this heterogeneity among study designs might be an explanation for differences 
found in the response of cytokines to training. Very little is known about the specific time course 
of expression levels and circulating levels of well-investigated and recently discovered cytokines 
after an exercise bout. This knowledge is needed to interpret each study on its merits. 
 
Limitations. Microarray analysis was performed in a subgroup of nine women, which limited 
statistical power. Both circulating levels and mRNA expression levels of cytokines in skeletal 
muscle were analyzed. Since these subgroups were a good representation of the whole group, we 
do not expect larger numbers would have altered the main outcomes of our study. In this study 
pre-, peri- and post-menopausal women were included, which provides a well representation of 
the entire female population in this age category. Although the menopause affects fat 
distribution, its effects on cytokines is less clear.(27, 29) We therefore do not believe that the 
main outcome of this study is influenced by menopausal status. In this study we explored 
cytokine expression levels in skeletal muscle, whilst adiponectin, omentin and vaspin might not 
be expressed in this tissue. However, gene expression analysis allows us to examine the potential 
role of skeletal muscle as source for circulating cytokines. Since white adipose tissue is also an 
important source for circulating cytokines, future work should examine expression changes in 
this tissue.(40) 
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Conclusion 
In conclusion, this study shows that exercise training successfully improves insulin sensitivity 
and physical fitness in both women with the metabolic syndrome and lean controls. The 
improvement in insulin sensitivity after exercise training was not accompanied by or correlated 
with changes in circulating levels or gene expression levels in skeletal muscle of novel (i.e. 
fractalkine, omentin, osteopontin and vaspin) and traditional (i.e. leptin, adiponectin and IL-6) 
cytokines. Our data may suggest that exercise-induced improvements in insulin sensitivity are 
not accompanied by a change in cytokines. 
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FIGURE Captions 
FIGURE 1. A. Insulin sensitivity (M-value) in women with the metabolic syndrome (MetS) 
before (□) and after (■) exercise training in women and in lean control women (C) before (○) 
and after (●) training. * P-value < 0.05 
 
Figure 2. Circulating levels of cytokines before (□) and after (■) exercise training in women 
with the metabolic syndrome (MetS) and in lean control women (C) before (○) 
and after (●) training. A. Fractalkine; B. Omentin. C. Osteopontin. D. Vaspin (only baseline  
values shown). E. Leptin. F. Adiponectin. * P-value < 0.05. 
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Supplemental Digital Content 1 .docx—Characteristics of the entire group versus the subgroups 
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TABLE 1. Physiological characteristics before and after exercise training. 
 
 
Women with MetS (n=11) Lean control women 
(n=10) 
P-value 
 Pre Post Pre Post Time Group Interaction 
Age (years) 53.2±7.2  48.5±10.2  - 0.24 - 
Body composition (anthropometry)      
Weight (kg) 96.4±11.3 94.8±9.6 67.0±6.6
# 66.9±6.2 0.18 <0.001 0.201 
Body mass index (kg/m²) 34.5±3.2 34.0±2.9 22.8±1.7
# 22.7±1.5 0.18 <0.001 0.23 
Waist (cm) 108.6±9.4 105.0±8.3 80.4±6.4
# 78.7±4.7 0.03 <0.001 0.97 
Waist-to-hip ratio 0.91±0.08 0.90±0.07 0.80±0.05* 0.78±0.04 0.57 <0.001 0.22 
Body composition (DXA)        
Lean body mass (kg) 56.6±7.2 55.9±6.4 47.2±4.3* 47.4±4.1 0.62 0.002 0.24 
Total fat mass (kg) 38.6±6.5 37.6±5.8 19.2±4.3
# 18.7±3.9 0.08 <0.001 0.61 
Trunk fat mass (kg) 20.2±4.0 19.5±3.1 8.4±2.8
# 8.0±2.4 0.09 <0.001 0.54 
Trunk fat percentage 
(%) 
52.4±5.1 52.0±4.8 42.9±7.1* 42.6±7.0 0.47 0.002 0.91 
Blood markers        
Fasting glucose (mmol/l) 5.5±0.6 5.7±0.8 4.5±0.3
#
 4.7±0.4 0.10 <0.001 0.85 
Insulin (mE/l) 17.4±10.4 15.4±5.2 8.9±3.0
# 10.0±3.8 0.76 0.013 0.24 
HDL-cholesterol 
(mmol/l) 
1.21±0.30 1.38±0.29 1.59±0.29 1.58±0.19 0.49 0.007 0.29 
Triglycerides (mmol/l) 1.98±0.84 1.83±0.66 0.87±0.27* 0.92±0.22 0.61 <0.001 0.22 
Free fatty acids (mmol/l) 0.58±0.15 0.45±0.18 0.52±0.16 0.43±0.23 0.01 0.86 0.69 
Blood pressure & heart rate       
Systolic blood pressure 
(mmHg) 
138±11 132±11 120±9* 114±9 0.02 <0.001 0.99 
Diastolic blood pressure 
(mmHg) 
84±5 80±7 76±5* 73±6 0.03 0.001 0.90 
Resting heart rate (bpm) 68±5 59±7 60±7* 58±5 0.003 0.03 0.06 
Physical fitness        
VO2max (ml/min/kg) 22.8±4.5 25.3±3.8 32.0±4.7
# 35.6±5.5 <0.001 <0.01 0.32 
VO2max (ml/min/kg 
FFM) 
38.6±6.5 42.6±5.6 45.5±7.1* 50.4±7.8 <0.001 0.023 0.48 
Power (Watt) 158±28 185±23 180±21 205±27 <0.001 0.05 0.83 
Menopausal status        
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Pre-menopausal (n) 2 - 3 - - - - 
Peri-menopausal (n) 4 - 4 - - - - 
Post-menopausal (n) 5 - 4 - - - - 
significantly different from Mets at baseline * P < 0.05; 
#
P < 0.001 
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TABLE 2. Micro-array results for gene-expression in skeletal muscle. 
 Women with MetS (n=5)          Healthy control women (n=4) 
 
P-value 
Corrected 
P-value 
Fold 
Change 
P-value 
Corrected 
P-value 
Fold 
Change 
Fractalkine (ng/ml) 0.492269 0.997875 -1.16 0.544348 0.957122 -1.13 
Omentin (ng/ml) 0.970832 0.999025 -1.02 0.930327 0.99287 1.00 
Osteopontin (ng/ml) 0.514872 0.997875 1.06 0.40586 0.941683 -1.07 
Vaspin (ng/ml) 0.778275 0.997875 1.02 0.727007 0.974637 1.03 
Leptin (ng/ml) 0.0950706 0.997875 -1.20 0.485465 0.952995 1.03 
Adiponectin (μg/ml) 0.145784 0.997875 -1.91 0.973873 0.996383 1.02 
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Table, Supplemental Digital Content 1 
Characteristics of the entire group versus the subgroups 
 
 Metabolic syndrome Controls 
 All subjects 
(n=11) 
Array cohort 
(n=6) 
All subjects 
(n=10) 
Array cohort 
(n=6) 
Age (years) 53 ± 7 58 ± 5 49 ± 10 50 ± 9 
Weight (kg) 96.4 ± 11.3 105.8 ± 7.1 67.0 ± 6.6 64.5 ± 6.0 
BMI (kg/m²) 34.5 ± 3.2 36.7 ± 2.0 22.8 ± 1.7 22.2 ± 1.0 
Waist-to-hip ratio 0.91 ± 0.08 0.95 ± 0.08 0.80 ± 0.05 0.78 ± 0.04 
M-value (mg/min/kg) 4.0 ± 1.8 3.1 ± 2.0 8.1 ± 1.9 8.6 ± 2.1 
HDL-cholesterol 
(mmol/l) 
1.21 ± 0.30 1.38 ± 0.40 1.59 ± 0.29 1.53 ± 0.32 
Triglycerides (mmol/l) 1.98 ± 0.84 1.83 ± 0.89 0.87 ± 0.27 0.98 ± 0.23 
Systolic blood 
pressure (mmHg) 
138 ± 11 143 ± 13 120 ± 9 117 ± 8 
Diastolic blood 
pressure (mmHg) 
84 ± 5 83 ± 5 76 ± 5 75 ± 5 
Resting heart rate 
(bpm) 
68 ± 5 68 ± 4 60 ± 7 59 ± 5 
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